Novavax COVID vaccine Nuvaxovid recommended for expanded conditional marketing authorization in EU for adolescents Ruchika Sharma26 Jun 2022 12:30 PM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax COVID vaccine gets emergency use nod in Taiwan for adults Ruchika Sharma24 Jun 2022 11:33 AM ISTNVX-CoV2373 is a protein-based vaccine engineered from the genetic sequence of the first strain of SARS-CoV-2, the virus that causes COVID-19 disease.
Novavax seeks UK nod for Nuvaxovid use in adolescents aged 12 through 17 years Ruchika Sharma5 May 2022 11:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
Novavax partner gets Japenese nod for Nuvaxovid Ruchika Sharma19 April 2022 5:18 PM ISTNovavax licensed and transferred its manufacturing technologies and is supplying the Matrix-M adjuvant to enable Takeda to manufacture the vaccine at...
Novavax seeks conditional marketing nod for Nuvaxovid in adolescents Ruchika Sharma3 April 2022 9:00 AM ISTGaithersburg: Novavax, Inc. has announced submission of its request to expand the conditional marketing authorization (CMA) of Nuvaxovid COVID-19...
Novavax's COVID vaccine rollout in EU off to a slow start -data MD Bureau15 March 2022 2:42 PM ISTThe Novavax vaccine, the latest to receive the EU regulators' approval under the trade name of Nuvaxovid, was expected to persuade some sceptics...
Novavax COVID vaccine gets nod in Canada Ruchika Sharma18 Feb 2022 1:02 PM ISTGaithersburg: Novavax, Inc. has recently announced that Health Canada has granted authorization for Nuvaxovid COVID-19 Vaccine (Recombinant protein,...
Novavax COVID vaccine gets interim authorization in Singapore Ruchika Sharma15 Feb 2022 10:00 AM ISTGaithersburg: Novavax, Inc has recently announced that the Singapore Health Sciences Authority (HSA) has issued interim authorization for...
Novavax COVID Vaccine gets conditional marketing nod in Great Britain Ruchika Sharma6 Feb 2022 9:00 AM ISTNVX-CoV2373 contains purified protein antigen and can neither replicate, nor can it cause COVID-19.
Australia gets 5th approved Covid-19 vaccine in Novavax Dr. Divya Colin23 Jan 2022 10:45 AM ISTThe Novavax vaccine will be available to unvaccinated Australians aged 18 years and older but will not be used as a booster for the 95% of the...
WHO advisory group issues interim recommendations for Covovax use Ruchika Sharma23 Dec 2021 10:00 AM ISTGaithersburg: Novavax, Inc. has announced that the World Health Organization (WHO) Strategic Advisory Group of Experts on Immunization...
SII, Novavax get WHO EUL for Covovax Ruchika Sharma18 Dec 2021 2:32 PM ISTGaithersburg: Novavax, Inc. and Serum Institute of India Pvt. Ltd. (SII), the world's largest vaccine manufacturer by volume, have announced that the...
